• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Alcohol use disorder may be associated with human immunodeficiency virus

byJayden BerdugoandAlex Chan
May 3, 2025
in Chronic Disease, Infectious Disease, Psychiatry, Public Health, Rheumatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Alcohol Use Disorder Diagnoses Among Individuals Who Take HIV Preexposure Prophylaxis

1. In this cohort of individuals taking preexposure prophylaxis (PrEP), there was an increase in the development of an alcohol use disorder (AUD) within 6 months of initiation.  

Evidence Rating Level: 2 (Good) 

One way to prevent the human immunodeficiency virus (HIV) epidemic is the use of preexposure prophylaxis (PrEP). There are several important stages of taking PrEP, which may be affected by outside factors such as alcohol use. The existing literature shows mixed findings regarding PrEP adherence and continuation in association with alcohol use. To build on this lacking literature, this retrospective cohort study was conducted to estimate the prevalence of alcohol use disorder (AUD) diagnoses before and after PrEP initiation. Individuals between the ages of 16 and 64 at the initiation time were included in the study. The primary outcome of this study was AUD diagnosis. Based on this, the cohort was divided into three groups: AUD diagnosis before initiation, AUD diagnosis after initiation, and individuals without AUD diagnoses at baseline or during the follow-up periods. After eligibility criteria were met, a total of 43,913 individuals taking PrEP were included (mean [SD] age 35.80 [10.94] years). Among them, 38,050 (86.65%) received TDF/FTC, and 5863 (13.35%) received TAF/FTC. After six months of PrEP initiation, 6274 (14.29%) individuals had a diagnosis of AUD, with 1245 (2.84%) receiving their diagnosis at baseline, and 5029 (11.45%) receiving their diagnosis after starting PrEP. Whether AUD diagnosis was received before or after initiation of PrEP, the associated sociodemographic and clinical factors remained similar. Specifically, male sex assigned at birth (before: adjusted odds ratio [aOR], aOR, 0.62; 95% CI, 0.52-0.73; after: aOR, 0.81; 95% CI 0.52-0.73; after: aOR, 0.81; 95% CI, 0.73-0.90) and mental health conditions such as depression (before: aOR, 2.36; 95% CI, 2.78-3.84; after: aOR, 3.17; 95% CI, 2.88-3.49). Overall, in this cohort study of individuals taking PrEP, almost 15% had an AUD diagnosis within 6 months of initiation. 

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

Second-line TAF-based ART improves viral suppression in pediatric HIV

Worsening kidney function observed following SARS-CoV-2 infection in children

Tags: HIVhuman immunodeficiency virusesinfectious diseasepre-exposure prophylaxis (PrEPprep
Previous Post

Cannabis use frequency increased following legalization with a decrease in misuse observed

Next Post

2 Minute Medicine Rewind May 5, 2025

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Trimethoprim-sulfamethoxazole during pregnancy does not reduce risk of prematurity

June 9, 2025
Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Second-line TAF-based ART improves viral suppression in pediatric HIV

June 4, 2025
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF

May 22, 2025
Next Post
UTI associated with increased risk of preeclampsia

2 Minute Medicine Rewind May 5, 2025

#VisualAbstract: Baloxavir Treatment is Effective in Preventing Transmission of Influenza

#VisualAbstract: Baloxavir Treatment is Effective in Preventing Transmission of Influenza

Surgical site anesthetic infusion may enhance analgesia after mastectomy

Routine confirmatory testing for primary aldosteronism may have low diagnostic value

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Food compounds associated with disease activity in inflammatory bowel disease 
  • Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts
  • Volumetric diet and time-restricted eating demonstrate similar outcomes for weight reduction
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.